Fact Sheet – Biotechnology Industry

2012

Global:

• The global biotech industry was $84.6 billion in 2010 and is expected to grow at a 7% CAGR to

$103 billion by 2013

Major Markets: USA, Europe, Australia, Asia-Pacific, Canada

Growth Drivers

• Active participation by private players

• Rising information technology innovation

• Improving healthcare infrastructure worldwide

Major issues

• Increasing regulatory demands, increasing funding and innovation pressures, environment

sustainability, food safety and security, human health & medicine

India:

• The Indian biotech Industry was Rs.17249.34 crores and is expected to grow at 21.5 % CAGR.

India contributed 28.66% to overall USD 128.26 billion Asia – Pacific market. It is expected to

reach USD 11.7 Billion by 2017

Major Segments and Contribution

• Biopharma – 61.77%, Bioservices -18.82%, Bioagri – 14.38%, BioIndustrial – 3.63%,

Bioinformatics – 1.41%. Bioagri is promising field which is growing at rate of 28%

Growth Drivers

• India’s large population is huge market for Biotech products

• Increased healthcare expenditure due to rising income

• Strong growth in export demand

• Increasing number of Indian pharmaceutical players entering into biotech segment

Positives: India's human gene pools offering an exciting opportunity for genomics

Negatives: Radical cost-cutting in healthcare budgets coupled with escalating drug development

costs

Major Issues: Intellectual Property Rights is granted only for invention and not for discoveries, in

India

Sources:

• Bourne Capital Partners – June 2011, E&Y Beyond Borders –Global Biotechnology Report 2011, Biospectrumindia -The Ninth Survey

of Indian Biotech Industry June 2011, businesstoday.intoday.in, ENVIS Newsletter on Environmental Biotechnology of Ministry Of Environment & Science, Govt.of India, www.fbae.org(Foundation for Biotechnology Awareness and Education)

• Interlink Knowledge Cell